Transform Wealth’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-108,650
Closed -$8.07M 265
2023
Q1
$8.07M Sell
108,650
-53
-0% -$4.44K 0.76% 46
2022
Q4
$10.1M Sell
108,703
-1,529
-1% -$148K 1.14% 25
2022
Q3
$10.5M Buy
110,232
+3,135
+3% +$310K 1.37% 15
2022
Q2
$9.92M Buy
107,097
+1,141
+1% +$111K 1.48% 15
2022
Q1
$10.7M Buy
105,956
+2,318
+2% +$244K 1.2% 23
2021
Q4
$10.7M Buy
103,638
+3,622
+4% +$335K 1.12% 26
2021
Q3
$8.49M Buy
+100,016
New +$8.38M 0.97% 33
2018
Q1
Sell
-14,231
Closed -$1.03M 242
2017
Q4
$1.03M Buy
14,231
+1,031
+8% +$75K 0.19% 146
2017
Q3
$1.07M Buy
13,200
+617
+5% +$48.8K 0.37% 96
2017
Q2
$1.01M Sell
12,583
-19
-0.2% -$1.5K 1.14% 33
2017
Q1
$989K Sell
12,602
-13,449
-52% -$1.07M 0.37% 100
2016
Q4
$2.06M Buy
26,051
+4,366
+20% +$353K 0.82% 26
2016
Q3
$1.93M Buy
21,685
+2,251
+12% +$212K 0.83% 29
2016
Q2
$1.86M Buy
+19,434
New +$1.94M 0.78% 27

Other funds holding CVS

Transform Wealth's CVS Position: Q2 2023 in Review

Transform Wealth sold out of CVS Health (CVS) in Q2 2023, closing a stake of 108,650 shares — an estimated $8.07M sold.

Transform Wealth first reported a position in CVS in Q2 2016 and held it in 14 quarters. The position peaked at $10.7M in Q1 2022. 2,204 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Transform Wealth reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Transform Wealth sold 108,650 CVS Health shares in Q2 2023, an estimated $8.07M.
  • Transform Wealth first reported a position in CVS Health in Q2 2016 and held it in 14 quarters.
  • Transform Wealth's CVS Health position peaked at $10.7M in Q1 2022.
  • 2,204 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Transform Wealth's 13F filing for Q2 2023, filed 14 Jul 2023.